Literature DB >> 12581562

Is it more important to quit smoking than which chemotherapy is used?

Carolyn M Dresler1.   

Abstract

Many patients continue to smoke after their diagnosis of cancer. It is a critically important time to work with the patient to have them stop smoking. Many oncologists may underestimate the potential interactions of smoking with their anti-tumor therapy. The detrimental possibilities are examined as they relate to surgery, radiation and most importantly, to chemotherapy. Oncologists must become more active in working with their continuing smokers in order to aid in their response to interventions. Documentation of smoking status is critical to report in future studies that have evaluated therapeutic options. Copyright 2002 Elsevier Science Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12581562     DOI: 10.1016/s0169-5002(02)00455-5

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  12 in total

1.  A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial.

Authors:  Elyse R Park; Sandra Japuntich; Jennifer Temel; Michael Lanuti; Jennifer Pandiscio; Joanna Hilgenberg; Diane Davies; Carolyn Dresler; Nancy A Rigotti
Journal:  J Thorac Oncol       Date:  2011-06       Impact factor: 15.609

2.  A snapshot of smokers after lung and colorectal cancer diagnosis.

Authors:  Elyse R Park; Sandra J Japuntich; Nancy A Rigotti; Lara Traeger; Yulei He; Robert B Wallace; Jennifer L Malin; Jennifer P Zallen; Nancy L Keating
Journal:  Cancer       Date:  2012-01-23       Impact factor: 6.860

3.  Integrating tobacco treatment into thoracic oncology settings: Lessons learned.

Authors:  Sandra J Japuntich; Christina M Luberto; Joanna M Streck; Nancy A Rigotti; Jennifer Temel; Michael Lanuti; Carolyn Dresler; Jennifer P Zallen; Diane Davies; Elyse R Park
Journal:  J Health Psychol       Date:  2015-06-04

4.  Disparities between blacks and whites in tobacco and lung cancer treatment.

Authors:  Elyse R Park; Sandra J Japuntich; Lara Traeger; Sheila Cannon; Hannah Pajolek
Journal:  Oncologist       Date:  2011-09-29

Review 5.  Smoking cessation: an integral part of lung cancer treatment.

Authors:  Janine K Cataldo; Sarita Dubey; Jodi J Prochaska
Journal:  Oncology       Date:  2010-08-11       Impact factor: 2.935

6.  Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0].

Authors:  Jamie S Ostroff; Elyse R Park; Brett M Goshe; Autumn W Rasmussen; Lynne I Wagner; JoRean D Sicks; Ilana F Gareen; Ruth C Carlos; Benjamin A Herman; Angela Wangari Walter; Susan Regan; Douglas E Levy; Irene Mahon; Alona Muzikansky; Jordan M Neil; Michelle Lui; Deepika Dilip; Laura Malloy; Irina Gonzalez; Lucy Finkelstein-Fox; Caitlin McCann; Elissa Perez
Journal:  BMC Public Health       Date:  2022-07-15       Impact factor: 4.135

7.  Nicotine enhances the antiapoptotic function of Mcl-1 through phosphorylation.

Authors:  Jinfeng Zhao; Meiguo Xin; Ton Wang; Yangde Zhang; Xingming Deng
Journal:  Mol Cancer Res       Date:  2009-11-10       Impact factor: 5.852

8.  Integrating tobacco treatment into cancer care: Study protocol for a randomized controlled comparative effectiveness trial.

Authors:  Elyse R Park; Jamie S Ostroff; Giselle K Perez; Kelly A Hyland; Nancy A Rigotti; Sarah Borderud; Susan Regan; Alona Muzikansky; Emily R Friedman; Douglas E Levy; Susan Holland; Justin Eusebio; Lisa Peterson; Julia Rabin; Jacob Miller-Sobel; Irina Gonzalez; Laura Malloy; Maureen O'Brien; Suhana de León-Sanchez; C Will Whitlock
Journal:  Contemp Clin Trials       Date:  2016-07-19       Impact factor: 2.226

9.  Stigmatic and Sympathetic Attitudes Toward Cancer Patients Who Smoke: A Qualitative Analysis of an Online Discussion Board Forum.

Authors:  Christina M Luberto; Kelly A Hyland; Joanna M Streck; Brandon Temel; Elyse R Park
Journal:  Nicotine Tob Res       Date:  2016-07-05       Impact factor: 4.244

10.  Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer.

Authors:  Joseph A Greer; William F Pirl; Elyse R Park; Thomas J Lynch; Jennifer S Temel
Journal:  J Psychosom Res       Date:  2008-09-24       Impact factor: 3.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.